Podcast summary

Strategies in Combating Chronic Kidney Disease - Dr. Salvatore Viscomi

Talking Biotech with Dr. Kevin Folta episode artwork

Talking Biotech with Dr. Kevin Folta

Podcast • 05/17/26 • 40 mins

Listen to the full episode

Early kidney risk detection prevents “dialysis crashes”

Chronic kidney disease is massively prevalent yet often asymptomatic until patients suddenly “crash into dialysis.” Staging with two simple biomarker tests plus targeted triage enables prevention, protecting lives and health-system budgets.

Use two biomarkers because causes leave different traces

Creatinine/eGFR and urine albumin-to-creatinine capture different failure patterns. Outdoor/CKDU cases may show normal urine while blood worsens, whereas diabetes/hypertension often first leaks protein into urine—so using only one test misclassifies risk.

Global predictive analytics must be population-specific

Risk models built from one country’s diagnosed patients won’t generalize to worldwide prevention. Karna claims it curates alerts for asymptomatic subpopulations using longitudinal, local risk-factor data—because age, exposures, and genetics differ sharply by region.